氘
化学
电化学
组合化学
试剂
胺气处理
同位素标记
有机化学
有机合成
动力学同位素效应
化学合成
氢-氘交换
纳米技术
作者
Cui Zhang,Zhihao Yang,Linwei Wang,Youai Qiu
摘要
Abstract Deuterium labeling plays a pivotal role in pharmaceutical development by modulating physicochemical properties and enabling metabolic tracing. However, site-selective and programmable deuteration in amine-containing pharmaceuticals remains a formidable challenge, as it typically requires prefunctionalized and costly deuterated reagents that hamper scalability and practical utility. Here, we report an electrochemical strategy for synthesizing deuterated amine pharmaceuticals using D2O as a cost-effective deuterium source, enabling site selectivity, degree-programmable deuteration, and excellent deuterium incorporation. Central to this approach is the electrochemical conversion of toxic polyhalides into reactive deuterated building blocks in situ, facilitating the efficient synthesis of over 70 deuterated drugs, with selective mono-, di-, and trideuteration at the N-benzyl, N-methyl, O-benzyl, and S-benzyl positions, and broad functional-group tolerance. Collectively, we establish a platform integrating polyhalides valorization with precision isotopic editing for accessing high-value deuterated pharmaceuticals, especially amine-containing drugs bearing common metabolic soft spots such as benzyl and methyl motifs.
科研通智能强力驱动
Strongly Powered by AbleSci AI